Sign in
Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved DME
Carl W. Baker, MD, FASRS
Optical Coherence Tomography Angiographic (OCTA) Changes in Retinal Vasculature After Episcleral Plaque Brachytherapy (EPB) for Choroidal Melanoma
Brian C Toy, MD
2018
Category: Imaging